Medical News

RSS

WCH researchers identify new breast cancer gene

A new breast cancer gene has been identified in a study led by Women's College Hospital researcher Dr. Mohammad Akbari, who is also an assistant professor with the Dalla Lana School of Public Health at the University of Toronto.

28 Apr 2015

Hebrew University and Harvard researchers develop method to map circuitry of the brain

In new research published today by Nature Methods, scientists from the Hebrew University of Jerusalem and Harvard University have announced a "Neuronal Positioning System" (NPS) that maps the circuitry of the brain, similar to how a Global Positioning System (GPS) receiver triangulates one's location on the planet.

28 Apr 2015

Discovery of molecular reset button for internal body clock could help treat different disorders

An international team of scientists has discovered what amounts to a molecular reset button for our internal body clock. Their findings reveal a potential target to treat a range of disorders, from sleep disturbances to other behavioral, cognitive, and metabolic abnormalities, commonly associated with jet lag, shift work and exposure to light at night, as well as with neuropsychiatric conditions such as depression and autism.

28 Apr 2015

Gladstone researchers identify way to prevent MS development in mice

Scientists from the Gladstone Institutes have discovered a way to prevent the development of multiple sclerosis (MS) in mice. Using a drug that blocks the production of a certain type of immune cell linked to inflammation and autoimmunity, the researchers successfully protected against the onset of MS in an animal model of the disease.

28 Apr 2015

Study suggests that inhibiting FOXO1 protein could speed diabetic wound healing

A protein that normally fosters tissue repair instead acts to inhibit healing when sugar levels are high, according to a study in The Journal of Cell Biology. The role reversal helps explain why wounds heal slowly in people with diabetes.

28 Apr 2015

Consortium of researchers awarded NIH grant to establish District of Columbia Center for AIDS Research

An interdisciplinary, city-wide consortium of researchers, led by Alan E. Greenberg, MD, MPH, professor and chair, Department of Epidemiology and Biostatistics at Milken Institute School of Public Health (Milken Institute SPH) at the George Washington University, has received a grant from the National Institutes of Health for an expected $7.5 million over five years to fund the newly established District of Columbia Center for AIDS Research.

28 Apr 2015

Night shift workers classified as alert insomniacs have highest level of impairment in work productivity

A new study of night shift workers suggests that overnight occupational and cognitive impairment is more strongly correlated to insomnia than it is to sleepiness.

28 Apr 2015

Yale researchers successfully correct gene mutation that causes cystic fibrosis

Yale researchers successfully corrected the most common mutation in the gene that causes cystic fibrosis, a lethal genetic disorder. The study was published April 27 in Nature Communications.

28 Apr 2015

Research findings could offer new way to test for chemo brain in patients

UBC research shows that chemotherapy can lead to excessive mind wandering and an inability to concentrate. Dubbed 'chemo-brain,' the negative cognitive effects of the cancer treatment have long been suspected, but the UBC study is the first to explain why patients have difficulty paying attention.

28 Apr 2015

WHO sends additional medical supplies, health workers into earthquake-affected region in Nepal

WHO is surging additional medical supplies and health workers into the earthquake-affected region to help the Government of Nepal provide rapid medical assistance to the thousands who have been injured in Saturday's disaster.

28 Apr 2015

Universal Health Services announces net income of $174.3 million for first quarter 2015

Universal Health Services, Inc. announced today that its reported net income attributable to UHS was $174.3 million, or $1.73 per diluted share, during the first quarter of 2015 as compared to $138.1 million, or $1.38 per diluted share, during the comparable quarter of 2014.

28 Apr 2015

Vermillion reports expanded medical policy coverage of OVA1 test

Vermillion, Inc., a bio-analytical solutions company focused on gynecologic disease, today announced expanded medical policy coverage of its OVA1 test, following Blue Cross Blue Shield of Michigan's recent decision to include OVA1 in its medical policy guidelines.

28 Apr 2015

NASP, SmartBrief partner to launch first news brief dedicated to specialty pharmacy industry

The National Association of Specialty Pharmacy and SmartBrief recently partnered to deliver a daily newsletter providing the specialty pharmacy industry with a snapshot of the top news in the industry.

28 Apr 2015

MCW announces formation of four-party MOU to provide inadequate access to oral health care in Tanzania

As part of its Oral Health Care Initiative, which has the vision to improve oral health care for all Tanzanians, MCW announced today the formation of an historic four-party Memorandum of Understanding (MOU).

28 Apr 2015

MiMedx Group's revenue increases 108% to $40.8 million in first quarter 2015

MiMedx Group, Inc., the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today its record results for the first quarter of 2015.

28 Apr 2015

Multichannel Pipette accelerates sample screening and genotyping assays INTEGRA

INTEGRA has published a new customer video from the Institute of Clinical Chemistry research group at the Technical University of Munich (TUM), in which researcher Christina Thomas reviews how the VOYAGER multichannel pipette has accelerated their sample screening and genotyping assays.

From INTEGRA Biosciences 28 Apr 2015

Intarcia Therapeutics announces closing of $225 million synthetic royalty financing

Intarcia Therapeutics, Inc. today announced the closing of a $225 million synthetic royalty financing with an equity conversion option at a $5.5 billion Company valuation. Plans are to use these funds to accelerate the initiation of additional head-to-head comparative and switch studies of ITCA 650 vs. leading oral and injectable type 2 diabetes therapies.

28 Apr 2015

Medical News

WCH researchers identify new breast cancer gene

Hebrew University and Harvard researchers develop method to map circuitry of the brain

Discovery of molecular reset button for internal body clock could help treat different disorders

Gladstone researchers identify way to prevent MS development in mice

Study suggests that inhibiting FOXO1 protein could speed diabetic wound healing

Consortium of researchers awarded NIH grant to establish District of Columbia Center for AIDS Research

Night shift workers classified as alert insomniacs have highest level of impairment in work productivity

Yale researchers successfully correct gene mutation that causes cystic fibrosis

Research findings could offer new way to test for chemo brain in patients

WHO sends additional medical supplies, health workers into earthquake-affected region in Nepal

Universal Health Services announces net income of $174.3 million for first quarter 2015

Vermillion reports expanded medical policy coverage of OVA1 test

NASP, SmartBrief partner to launch first news brief dedicated to specialty pharmacy industry

MCW announces formation of four-party MOU to provide inadequate access to oral health care in Tanzania

MiMedx Group's revenue increases 108% to $40.8 million in first quarter 2015

Multichannel Pipette accelerates sample screening and genotyping assays INTEGRA

Intarcia Therapeutics announces closing of $225 million synthetic royalty financing

Boston Scientific, Brainlab form strategic collaboration

Two thirds of the world’s population have no access to safe and affordable surgery

MicroCare Medical Highlights its most Advanced Products at Med-Tech Innovations

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News